M.M. Jimenez

441 total citations
6 papers, 39 citations indexed

About

M.M. Jimenez is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, M.M. Jimenez has authored 6 papers receiving a total of 39 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in M.M. Jimenez's work include Cancer Immunotherapy and Biomarkers (2 papers), Breastfeeding Practices and Influences (1 paper) and Obesity, Physical Activity, Diet (1 paper). M.M. Jimenez is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Breastfeeding Practices and Influences (1 paper) and Obesity, Physical Activity, Diet (1 paper). M.M. Jimenez collaborates with scholars based in Spain, Belgium and United States. M.M. Jimenez's co-authors include Martin D. Berger, Edward Cha, Steven S. Raman, Yue Zhang, Alissa Keegan, Arlene Chan, Sumita Bhatta, Kevin Kalinsky, Alfredo Carrato and Maria Martinez‐García and has published in prestigious journals such as Cancer Research, Annals of Oncology and Appetite.

In The Last Decade

M.M. Jimenez

4 papers receiving 38 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.M. Jimenez Spain	3	31	14	10	7	5	6	39
Michael Parappilly United States	4	26 0.8×	9 0.6×	11 1.1×	5 0.7×	6 1.2×	9	43
Martin Hogg United Kingdom	2	22 0.7×	9 0.6×	5 0.5×	9 1.3×	8 1.6×	2	36
Alla Karpova United States	2	23 0.7×	10 0.7×	7 0.7×	4 0.6×	4 0.8×	4	41
Andrew R. Patterson United States	4	17 0.5×	27 1.9×	9 0.9×	5 0.7×	4 0.8×	6	61
Danni Zhu China	4	40 1.3×	37 2.6×	11 1.1×	4 0.6×	2 0.4×	4	59
Katharina Schreeb Germany	4	31 1.0×	34 2.4×	5 0.5×	11 1.6×	3 0.6×	7	71
Sam Nichols United Kingdom	2	36 1.2×	15 1.1×	9 0.9×	1 0.1×	5 1.0×	2	52
Rebecca A. DeStefanis United States	4	29 0.9×	5 0.4×	11 1.1×	2 0.3×	5 1.0×	6	44
Nathan Demars United States	4	27 0.9×	11 0.8×	3 0.3×	9 1.3×	1 0.2×	13	37
Sylvia M. Lee United States	2	60 1.9×	37 2.6×	6 0.6×	6 0.9×		4	65

Countries citing papers authored by M.M. Jimenez

Since Specialization

Citations

This map shows the geographic impact of M.M. Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Jimenez more than expected).

Fields of papers citing papers by M.M. Jimenez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.M. Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Jimenez. The network helps show where M.M. Jimenez may publish in the future.

Co-authorship network of co-authors of M.M. Jimenez

This figure shows the co-authorship network connecting the top 25 collaborators of M.M. Jimenez. A scholar is included among the top collaborators of M.M. Jimenez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.M. Jimenez. M.M. Jimenez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Curigliano, Giuseppe, M.M. Jimenez, Tomokazu Shimizu, et al.. (2024). A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies. ESMO Open. 9(8). 103643–103643. 7 indexed citations

2.

Ramírez‐Silva, Ivonne, Ana Carolina Ariza, M.M. Jimenez, et al.. (2023). Longitudinal patterns of breastfeeding and its association with adiposity and subjective indicators of satiety/appetite in the first 2 years of life. Appetite. 190. 107030–107030.

3.

Hecht, J. Randolph, Steven S. Raman, Arlene Chan, et al.. (2023). Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases. ESMO Open. 8(2). 100884–100884. 22 indexed citations

4.

Petit, A., María Teresa Soler-Monsó, Gema Pérez-Chacón, et al.. (2023). 289P Results of the window-of-opportunity clinical trial D-BIOMARK: Study of biomarkers of the antitumor activity of denosumab and its role as a modulator of the immune response in early breast cancer. Annals of Oncology. 34. S300–S300. 1 indexed citations

5.

Roché, Henri, Djelila Allouache, Gilles Romieu, et al.. (2009). Five-Year Analysis of the FNCLCC-PACS04 Trial: FEC100 vs ED75 for the Adjuvant Treatment of Node Positive Breast Cancer.. Cancer Research. 69(24_Supplement). 602–602. 8 indexed citations

6.

Jimenez, M.M., et al.. (1997). A Randomized Comparison of Intravenously Administered Chlorpromazine Plus Dexamethasone Vs Ondansetron Vs Tropisetron in the Prevention of Chemotherary-Induced Emesis in Children. Pediatric Research. 42(3). 399–399. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact